Literature DB >> 2619274

Microbial glycosylation of erythromycin A.

M S Kuo1, D G Chirby, A D Argoudelis, J I Cialdella, J H Coats, V P Marshall.   

Abstract

Erythromycin A (compound 1) was inactivated by Streptomyces vendargensis ATCC 25507 in fermentation. The inactivation product was isolated and characterized by nuclear magnetic resonance and mass spectroscopy as 2'-(O-[beta-D-glucopyranosyl])erythromycin A (compound 2). The MICs of compounds 1 and 2 were determined. Compound 2 lacked antibiotic activity when tested against several gram-positive pathogens, as well as S. vendargensis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2619274      PMCID: PMC172826          DOI: 10.1128/AAC.33.12.2089

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Structure of a phosphorylated derivative of oleandomycin, obtained by reaction of oleandomycin with an extract of an erythromycin-resistant strain of Escherichia coli.

Authors:  K O'Hara; T Kanda; M Kono
Journal:  J Antibiot (Tokyo)       Date:  1988-06       Impact factor: 2.649

2.  Microbial O-phosphorylation of macrolide antibiotics.

Authors:  V P Marshall; J I Cialdella; L Baczynskyj; W F Liggett; R A Johnson
Journal:  J Antibiot (Tokyo)       Date:  1989-01       Impact factor: 2.649

3.  Microbial transformation of antibiotics. V. Clindamycin ribonucleotides.

Authors:  A D Argoudelis; J H Coats
Journal:  J Am Chem Soc       Date:  1971-01-27       Impact factor: 15.419

4.  Enzymatic phosphorylation of macrolide antibiotics.

Authors:  P F Wiley; L Baczynskyj; L A Dolak; J I Cialdella; V P Marshall
Journal:  J Antibiot (Tokyo)       Date:  1987-02       Impact factor: 2.649

Review 5.  Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses.

Authors:  M Arthur; A Brisson-Noël; P Courvalin
Journal:  J Antimicrob Chemother       Date:  1987-12       Impact factor: 5.790

Review 6.  Evolution and transfer of aminoglycoside resistance genes under natural conditions.

Authors:  P Trieu-Cuot; P Courvalin
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

7.  Inactivation of lincosaminide antibiotics in Staphylococcus. Identification of lincosaminide O-nucleotidyltransferases and comparison of the corresponding resistance genes.

Authors:  A Brisson-Noël; P Delrieu; D Samain; P Courvalin
Journal:  J Biol Chem       Date:  1988-11-05       Impact factor: 5.157

8.  Microbial transformation of antibiotics: phosphorylation of clindamycin by Streptomyces coelicolor Müller.

Authors:  J H Coats; A D Argoudelis
Journal:  J Bacteriol       Date:  1971-10       Impact factor: 3.490

9.  Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria.

Authors:  R Benveniste; J Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

10.  Streptomycin biosynthesis and metabolism. Enzymatic phosphorylation of dihydrostreptobiosamine moieties of dihydro-streptomycin-(streptidino) phosphate and dihydrostreptomycin by Streptomyces extracts.

Authors:  M S Walker; J B Walker
Journal:  J Biol Chem       Date:  1970-12-25       Impact factor: 5.157

View more
  13 in total

1.  Role of glycosylation and deglycosylation in biosynthesis of and resistance to oleandomycin in the producer organism, Streptomyces antibioticus.

Authors:  C Vilches; C Hernandez; C Mendez; J A Salas
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

Review 2.  Avoidance of suicide in antibiotic-producing microbes.

Authors:  Eric Cundliffe; Arnold L Demain
Journal:  J Ind Microbiol Biotechnol       Date:  2010-05-06       Impact factor: 3.346

3.  New tenvermectin analogs obtained by microbial conversion with Saccharopolyspora erythraea.

Authors:  Xu Wan; Shao-Yong Zhang; Hui Zhang; Jun Zhai; Jun Huang; An-Liang Chen; Ji-Dong Wang
Journal:  J Antibiot (Tokyo)       Date:  2016-07-20       Impact factor: 2.649

4.  Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation.

Authors:  E R Dabbs; K Yazawa; Y Mikami; M Miyaji; N Morisaki; S Iwasaki; K Furihata
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

5.  Inactivation of rifampin by Nocardia brasiliensis.

Authors:  K Yazawa; Y Mikami; A Maeda; M Akao; N Morisaki; S Iwasaki
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

6.  Glycosylation of macrolide antibiotics in extracts of Streptomyces lividans.

Authors:  E Cundliffe
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

7.  Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides.

Authors:  L Wondrack; M Massa; B V Yang; J Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

8.  Microbial conversion of avermectins by Saccharopolyspora erythraea: glycosylation at C-4' and C-4''.

Authors:  M Schulman; P Doherty; B Arison
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

9.  Inactivation of the macrolide antibiotics erythromycin, midecamycin, and rokitamycin by pathogenic Nocardia species.

Authors:  K Yazawa; Y Mikami; T Sakamoto; Y Ueno; N Morisaki; S Iwasaki; K Furihata
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

10.  Characterization of a glycosyl transferase inactivating macrolides, encoded by gimA from Streptomyces ambofaciens.

Authors:  A Gourmelen; M H Blondelet-Rouault; J L Pernodet
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.